Covishield Vaccine By Siam Bioscience Qualified For Utilization

Oxford-AstraZeneca Vaccine called the Covishield Vaccine had been allowed to be domestically produced by Siam Bioscience Co., Ltd. had been pronounced suitable for the coronavirus disease 2019 immunization, under the standards provided by the Department of Medical Sciences.
Director-General Doctor Supakit Sirilak revealed on Tuesday, April 27 that specimens of five varieties of the vaccine, which had been examined for dependability for mass production was handed out DMSc for sanction.